Administration of zolpidem in the late section of pregnancy or for the duration of labour has long been affiliated with outcomes on the neonate, for example hypothermia, hypotonia, feeding challenges (‘floppy infant syndrome’) and respiratory depression due to pharmacological action of the solution.